PROS Brief Smoking Cessation Counseling in Pediatric Practice to Reduce Secondhand Smoke Exposure of Young Children
NCT ID: NCT00135213
Last Updated: 2008-01-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
1200 participants
INTERVENTIONAL
2005-10-31
2007-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* refine components of office systems and counseling interventions for parental tobacco control in pediatric outpatient settings; and
* pilot test the feasibility and efficacy of a parental tobacco control randomized controlled trial in pediatric office settings using 5 intervention and 5 comparison pediatric practice sites.
The investigators hypothesize that:
* clinicians in intervention practices (compared to those in control practices) will more often implement successful office systems, screen for parental smoking, advise parents to quit and to prohibit smoking and SHS exposure at home, recommend pharmacotherapy, provide adjuncts, and refer parents to cessation programs; and
* parents who smoke in intervention practices (measured by 3-month follow-up telephone surveys) will be more likely than those in control practices to have received cessation services, use pharmacotherapy, make lasting quit attempts, and institute rules to prohibit smoking and limit SHS exposure at home.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PROS Smokebusters: Adolescent Smoking Cessation in Pediatric Primary Care
NCT00135265
Effect of Using a Structured Tobacco Cessation Education Program
NCT00683228
Provider and Peer Delivered Youth Smoking Intervention
NCT00435344
School Nurse-Delivered Smoking Cessation Intervention
NCT00682474
A Study of Tobacco Smoke and Children With Respiratory Illnesses
NCT03062709
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* refine components of office systems and counseling interventions for parental tobacco control in pediatric outpatient settings; and
* pilot test the feasibility and efficacy of a parental tobacco control randomized controlled trial in pediatric office settings using 5 intervention and 5 comparison pediatric practice sites.
The investigators hypothesize that:
* clinicians in intervention practices (compared to those in control practices) will more often implement successful office systems, screen for parental smoking, advise parents to quit and to prohibit smoking and SHS exposure at home, recommend pharmacotherapy, provide adjuncts, and refer parents to cessation programs; and
* parents who smoke in intervention practices (measured by 3-month follow-up telephone surveys) will be more likely than those in control practices to have received cessation services, use pharmacotherapy, make lasting quit attempts, and institute rules to prohibit smoking and limit SHS exposure at home.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
PREVENTION
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
training in smoking cessation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Physicians are eligible if they are able and willing to provide informed consent and have a patient flow of several children per week, and are not currently participating in another PROS study. They also must be able to read and speak English.
* Eligible parents will:
* be parents or guardians age 18 or older;
* be parents of a child aged 0-6;
* have access to a telephone; and
* be able to speak/read English.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Truth Initiative
OTHER
Robert Wood Johnson Foundation
OTHER
University of Rochester
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonathan D Klein, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Rochester
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Rochester
Rochester, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11585
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.